Detalhe da pesquisa
1.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
2.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Ann Hepatol
; 17(6): 959-968, 2018 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30600291
3.
The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C.
Immunology
; 151(2): 167-176, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28140446
4.
Predicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatment.
J Clin Gastroenterol
; 47(9): 786-93, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23442834
5.
Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial.
Ann Intern Med
; 150(8): 528-40, 2009 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19380853
6.
The First Complete Genome Sequences of Hepatitis C Virus Subtype 2b from Latin America: Molecular Characterization and Phylogeographic Analysis.
Viruses
; 11(11)2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31683566
7.
Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes.
PLoS One
; 14(5): e0216327, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31063475
8.
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
AIDS
; 22(14): 1779-87, 2008 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18753861